betapharm Arzneimittel GmbH v. Amgen Inc.: Discovery Application

Application by betapharm Arzneimittel GmbH, of Germany, to take discovery from Amgen Inc., of Delaware, “for use in German patent infringement actions and opposition proceedings before the European Patent Office”, filed at the U. S. District Court for the Central District of California.

- You’re only seeing part of this content
  
  To view the entire article or download the document, subscribe today.
  
  – Offshore Courts: 29,000+ court cases (Bahamas, Bermuda, BVI, Cayman Islands)
  – Investigative Articles: 4,500+ in-depth articles, including fraud exposés
  – MLATs – Criminal: 1,400+ MLATs on global criminal investigations
  – Ch. 15 – Insolvencies: Monitored daily
  – Foreign Discovery: Applications for foreign discovery filed in the USA, monitored daily
  – Regulatory Actions: Global regulatory actions, fines, and bans, monitored daily
  – And More: Criminal indictments, extraditions, winding-up petitions, and more
  
  Unlimited access for less than $3/day.
  
  Cancel anytime.
  
  SUBSCRIBE
- SIGN IN
  
  Forgot your password?

Pages: 146

Date: May 06, 2021

Plaintiffs/Applicants: betapharm Arzneimittel GmbH

Case Number: Xx Xx Xx

Defendants/Respondents: Amgen Inc.

Plaintiffs/Applicants Attorneys: Foley & Lardner, Kimberly Dodd

Topics

Germany USA

Keywords

Amgen Inc. betapharm Arzneimittel GmbH

BECOME A SUBSCRIBER

Daily red flags in high-value international finance

Unlimited access. No contracts. Cancel anytime.